Company is among the first in China's drug-device combination products sector to obtain this certification, delivering superior solutions to global clients Zero non-conformities demonstrates company's robust quality management system SHANGHAI, April 14, 2026 /PRNewswire/ -- WuXi Biologics...
Hence then, the article about wuxi biologics achieves iso 13485 certification signifying strong capabilities in drug device combination product development and manufacturing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing )
Also on site :
- Julie Greenwald and Max Lousada Launch 26.2, a New Label, in Partnership With Sony Music
- Vast search underway in Ecuador to locate missing Chicago-area native, Fenwick HS alumnus
- Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds